132 related articles for article (PubMed ID: 24523441)
21. Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells.
Wöltje K; Jabs M; Fischer A
PLoS One; 2015; 10(3):e0120547. PubMed ID: 25799559
[TBL] [Abstract][Full Text] [Related]
22. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
23. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
Belyea BC; Naini S; Bentley RC; Linardic CM
Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids inhibit notch target gene expression in osteoblasts.
Zanotti S; Yu J; Adhikari S; Canalis E
J Cell Biochem; 2018 Jul; 119(7):6016-6023. PubMed ID: 29575203
[TBL] [Abstract][Full Text] [Related]
26. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.
Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A
Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041
[TBL] [Abstract][Full Text] [Related]
27. mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis.
Roy D; Sin SH; Lucas A; Venkataramanan R; Wang L; Eason A; Chavakula V; Hilton IB; Tamburro KM; Damania B; Dittmer DP
Cancer Res; 2013 Apr; 73(7):2235-46. PubMed ID: 23382046
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
Brun M; Jain S; Monckton EA; Godbout R
Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
[TBL] [Abstract][Full Text] [Related]
29. Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.
Yoo J; Lee HN; Choi I; Choi D; Chung HK; Kim KE; Lee S; Aguilar B; Kang J; Park E; Lee YS; Maeng YS; Kim NY; Koh CJ; Hong YK
PLoS Pathog; 2012; 8(6):e1002770. PubMed ID: 22719258
[TBL] [Abstract][Full Text] [Related]
30. SUMOylation Fine-Tunes Endothelial HEY1 in the Regulation of Angiogenesis.
Ren R; Ding S; Ma K; Jiang Y; Wang Y; Chen J; Wang Y; Kou Y; Fan X; Zhu X; Qin L; Qiu C; Simons M; Wei X; Yu L
Circ Res; 2024 Jan; 134(2):203-222. PubMed ID: 38166414
[TBL] [Abstract][Full Text] [Related]
31. The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk.
Han L; Diehl A; Nguyen NK; Korangath P; Teo W; Cho S; Kominsky S; Huso DL; Feigenbaum L; Rein A; Argani P; Landberg G; Gessler M; Sukumar S
Cancer Res; 2014 Nov; 74(22):6509-18. PubMed ID: 25217524
[TBL] [Abstract][Full Text] [Related]
32. ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.
Savino B; Caronni N; Anselmo A; Pasqualini F; Borroni EM; Basso G; Celesti G; Laghi L; Tourlaki A; Boneschi V; Brambilla L; Nebuloni M; Vago G; Mantovani A; Locati M; Bonecchi R
Cancer Immunol Res; 2014 Jul; 2(7):679-89. PubMed ID: 24844911
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of Cell Surface Glycoproteins in Correlation with KSHV LANA in the Kaposi Sarcoma Tumor Microenvironment.
Privatt SR; Ngalamika O; Zhang J; Li Q; Wood C; West JT
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046832
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.
Sahu A; Devi S; Jui J; Goldman D
Glia; 2021 Dec; 69(12):2882-2898. PubMed ID: 34415582
[TBL] [Abstract][Full Text] [Related]
35. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.
Koon HB; Fingleton B; Lee JY; Geyer JT; Cesarman E; Parise RA; Egorin MJ; Dezube BJ; Aboulafia D; Krown SE
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):64-8. PubMed ID: 21068672
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma as a model of oncogenesis and cancer treatment.
Hansen A; Boshoff C; Lagos D
Expert Rev Anticancer Ther; 2007 Feb; 7(2):211-20. PubMed ID: 17288530
[TBL] [Abstract][Full Text] [Related]
37. IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
Yang YF; Wang YY; Hsiao M; Lo S; Chang YC; Jan YH; Lai TC; Lee YC; Hsieh YC; Yuan SF
Cancer Lett; 2020 Aug; 485():27-37. PubMed ID: 32417395
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of the Notch pathway as a common road in viral carcinogenesis.
Vázquez-Ulloa E; Lizano M; Sjöqvist M; Olmedo-Nieva L; Contreras-Paredes A
Rev Med Virol; 2018 Sep; 28(5):e1988. PubMed ID: 29956408
[TBL] [Abstract][Full Text] [Related]
39. Hey1 promotes migration and invasion of melanoma cells via GRB2/PI3K/AKT signaling cascade.
Pu Y; Lei M; Chen Y; Huang Y; Zhang L; Chen J; Zhang Y; Shao X; Liu L; Chen J
J Cancer; 2021; 12(23):6979-6988. PubMed ID: 34729100
[TBL] [Abstract][Full Text] [Related]
40. Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study.
Gaetani P; Hulleman E; Levi D; Quarto M; Scorsetti M; Helins K; Simonelli M; Colombo P; Baena y Rodriguez R
Tumori; 2010; 96(1):97-102. PubMed ID: 20437865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
